Literature DB >> 8963073

Cystoid macular edema.

C J Quinn1.   

Abstract

Cystoid macular edema (CME) may develop in association with a wide variety of ocular conditions. It is the result of cystic accumulation of extracellular intraretinal fluid in the outer plexiform and inner nuclear layers of the retina, as a result of breakdown of the blood-retinal barrier. It is most common following intraocular surgery, and in patients with venous occlusive disease, diabetic retinopathy, and posterior segment inflammatory conditions. A variety of approaches to the treatment of CME have been attempted, with a variable degree of success. These options have included topical and oral steroids, nonsteroidal anti-inflammatory agents, and laser photocoagulation treatment. The exact cause of CME and the effective treatment of this condition have remained elusive.

Entities:  

Mesh:

Year:  1996        PMID: 8963073

Source DB:  PubMed          Journal:  Optom Clin        ISSN: 1050-6918


  13 in total

1.  Chronic cystoid macular oedema treated with intravitreal dobesilate.

Authors:  Pedro Cuevas; Luis A Outeiriño; Javier Angulo; Guillermo Giménez-Gallego
Journal:  BMJ Case Rep       Date:  2012-07-09

2.  Topical dorzolamide for treatment of cystoid macular edema in patients with choroideremia.

Authors:  Mohamed A Genead; Jason J McAnany; Gerald A Fishman
Journal:  Retina       Date:  2012-04       Impact factor: 4.256

3.  Managing diabetic macular edema: The leading cause of diabetes blindness.

Authors:  Pedro Romero-Aroca
Journal:  World J Diabetes       Date:  2011-06-15

4.  Cystic macular oedema on spectral-domain optical coherence tomography in choroideremia patients without cystic changes on fundus examination.

Authors:  M A Genead; G A Fishman
Journal:  Eye (Lond)       Date:  2010-10-22       Impact factor: 3.775

5.  Effects of long-term high-altitude exposure on retinal and choroidal microcirculation.

Authors:  Jinlan Ma; Haoyu Niu; Xiaolu Ma; Changjing Han; Yi Qu
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-06-09       Impact factor: 3.535

6.  Management of ocular inflammation and pain following cataract surgery: focus on bromfenac ophthalmic solution.

Authors:  Hyung Cho; Kenneth J Wolf; Eric J Wolf
Journal:  Clin Ophthalmol       Date:  2009-06-02

7.  Angiographic Cystoid Macular Edema and Outcomes in the Comparison of Age-Related Macular Degeneration Treatments Trials.

Authors:  Neepa Shah; Maureen G Maguire; Daniel F Martin; James Shaffer; Gui-Shuang Ying; Juan E Grunwald; Cynthia A Toth; Glenn J Jaffe; Ebenezer Daniel
Journal:  Ophthalmology       Date:  2016-01-08       Impact factor: 12.079

8.  Etiology and treatment of the inflammatory causes of cystoid macular edema.

Authors:  Hyung Cho; Assumpta Madu
Journal:  J Inflamm Res       Date:  2009-10-02

Review 9.  Ocular Effects of Niacin: A Review of the Literature.

Authors:  Daniela Domanico; Francesca Verboschi; Simona Altimari; Luigi Zompatori; Enzo Maria Vingolo
Journal:  Med Hypothesis Discov Innov Ophthalmol       Date:  2015

10.  Topical latanoprost does not cause macular thickening after uncomplicated cataract surgery.

Authors:  Sasan Moghimi; Mehdi Zandian; Golshan Latifi; Heydar Amini; Yadollah Eslami; Reza Zarei; Ghasem Fakhraie; Kouros Nouri-Mahdavi
Journal:  J Ophthalmic Vis Res       Date:  2012-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.